U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209394

MAVYRET (GLECAPREVIR; PIBRENTASVIR)
100MG;40MG
Marketing Status: Prescription
Active Ingredient: GLECAPREVIR; PIBRENTASVIR
Proprietary Name: MAVYRET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG;40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209394
Product Number: 001
Approval Date: Aug 3, 2017
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top